Pulmonx (STU:4NI) Construction In Progress : €0.07 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Pulmonx Construction In Progress?

Pulmonx's quarterly construction in progress declined from Sep. 2024 (€1.14 Mil) to Dec. 2024 (€0.20 Mil) and declined from Dec. 2024 (€0.20 Mil) to Mar. 2025 (€0.07 Mil).

Pulmonx's annual construction in progress increased from Dec. 2022 (€1.72 Mil) to Dec. 2023 (€2.02 Mil) but then declined from Dec. 2023 (€2.02 Mil) to Dec. 2024 (€0.20 Mil).

Pulmonx Construction In Progress Historical Data

The historical data trend for Pulmonx's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulmonx Construction In Progress Chart

Pulmonx Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Construction In Progress

Get a 7-Day Free Trial

0.37

1.18

1.72

2.02

0.20

Pulmonx Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Construction In Progress	Get a 7-Day Free Trial															2.07	0.93	1.14	0.20	0.07

Pulmonx Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Pulmonx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulmonx Corp (STU:4NI) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

LUNG:USA 4NI:Germany

Address

700 Chesapeake Drive, Redwood, CA, USA, 94063

Website

https://www.pulmonx.com

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Pulmonx Headlines

No Headlines